Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial.
Adv Sci (Weinh)
; 8(15): e2002751, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34081408
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tetanus
/
Tetanus Toxoid
/
Immunogenicity, Vaccine
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
En
Journal:
Adv Sci (Weinh)
Year:
2021
Document type:
Article